Alzamend Neuro, Inc. (ALZN) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-04-16

Alzamend Neuro, Inc. (ALZN) — no SEC Form 4 insider filings recorded in the last 90 days. 1 Form 8-K material event filings were reported by ALZN in the last 90 days. InsiderAlpha tracks every ALZN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Alzamend Neuro, Inc. (ALZN)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001677077

90-Day SEC Filing Activity

Form 8-K filings (90d)	1
Latest Form 4 filing	2026-04-16

Recent ALZN Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-04-14	AULT MILTON C III	Insider	P — Open-market purchase	108.4K	$1.00	$109K	SEC
2025-10-09	AULT MILTON C III	Insider	S — Open-market sale	20.4K	$2.32	$47K	SEC
2025-10-08	AULT MILTON C III	Insider	J — Other acquisition / disposition	61.7K	$2.32	$143K	SEC
2025-10-08	AULT MILTON C III	Insider	S — Open-market sale	101.4K	$2.44	$247K	SEC
2025-10-07	AULT MILTON C III	Insider	J — Other acquisition / disposition	100.0K	$2.32	$232K	SEC
2025-10-07	AULT MILTON C III	Insider	S — Open-market sale	57.4K	$2.49	$143K	SEC
2025-10-06	AULT MILTON C III	Insider	S — Open-market sale	82.0K	$2.45	$201K	SEC
2025-10-03	AULT MILTON C III	Insider	J — Other acquisition / disposition	100.0K	$2.32	$232K	SEC
2025-10-03	AULT MILTON C III	Insider	S — Open-market sale	65.9K	$2.44	$161K	SEC
2025-10-02	AULT MILTON C III	Insider	S — Open-market sale	20.7K	$2.39	$50K	SEC
2025-10-01	AULT MILTON C III	Insider	J — Other acquisition / disposition	100.0K	$2.32	$232K	SEC
2025-10-01	AULT MILTON C III	Insider	S — Open-market sale	36.8K	$2.35	$86K	SEC
2025-09-30	AULT MILTON C III	Insider	S — Open-market sale	3.6K	$2.33	$8K	SEC
2025-09-29	AULT MILTON C III	Insider	S — Open-market sale	38.3K	$2.31	$88K	SEC
2025-09-26	AULT MILTON C III	Insider	S — Open-market sale	37.7K	$2.31	$87K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Alzamend Neuro, Inc. (ALZN). Updated in real time as new filings are submitted to the SEC.

Recent ALZN Form 8-K Material Events

2026-04-17 — Item 5.07, 9.01 · Other · neutral [SEC]
Alzamend Neuro held its annual meeting of stockholders on April 17, 2026, where shareholders voted on seven proposals including the election of seven directors and ratification of the independent auditor. All proposals were approved by shareholders.
2026-03-20 — Item 3.01, 9.01 · Regulatory · negative [SEC]
Alzamend Neuro received a notice from Nasdaq on March 20, 2026 that its stockholders' equity of $2.2 million as of January 31, 2026 failed to meet the continued listing requirement of $2.5 million under Nasdaq Listing Rule 5550(b)(1). The company has until May 4, 2026 to submit a
2026-03-06 — Item 1.01, 9.01 · Financing · neutral [SEC]
Alzamend Neuro entered into an At-the-Market (ATM) Issuance Sales Agreement with Ascendiant Capital Markets to sell up to $3.0 million in common stock shares. The offering will be conducted under the company's existing shelf registration statement, allowing for periodic sales at

Recent Insider Filings

2026-04-16 — AULT MILTON C III (Insider)
2025-10-24 — McGrath Lynne Fahey (Insider)
2025-10-08 — AULT MILTON C III (Insider)
2025-10-03 — AULT MILTON C III (Insider)
2025-10-01 — AULT MILTON C III (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ALZN insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ALZN Insider Trading — FAQ

What is the latest insider trade for ALZN?: Alzamend Neuro, Inc. (ALZN) had 0 insider filings in the last 90 days, with the most recent on 2026-04-16. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ALZN stock?: 0 insider purchases of ALZN were filed in the last 90 days.
How many insiders are selling ALZN stock?: 0 insider sales of ALZN were filed in the last 90 days.
Where can I see ALZN SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ALZN SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live ALZN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.